Disability activist and inspiration for this site and the term adaptive PPE, Matthew Cortland is hosting a Twitter space to help people learn how to manage air quality in indoor spaces and generally protect themselves as the pandemic continues.
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.“Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV,” said PeterContinue…
